Use of crizotinib for refractory ALK-positive lymphomas - PDF (Russian)


Copyright (c) 2017 Shelikhova L.N., Fominykh V.V., Abramov D.S., Myakova N.V., Maschan M.A., Maschan A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies